Purchase Order 75F40123P00269
Award Date 8/7/23
Potential Completion Date 8/13/25
Potential Value $202K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Food and Drug Administration (FDA) awarded a $86,100.00 firm-fixed-price contract to Novabioassays LLC, a for-profit limited liability company, for contracted services to characterize end products and monitor critical quality attributes (CQAs), particularly charge variants and sequence variants, of biotherapeutics manufactured through continuous processing. The contract does not have a set-aside designation and is scheduled for completion by August 2, 2022. The contract does not...
- <p>This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to Bioproximity LLC, a for-profit limited liability company, for global proteomic profiling sample preparation and data services. The contract has a ceiling value of $89,100.00 and an ultimate completion date of August 2, 2016. This contract award is not associated with a larger vehicle and does not have a set-aside designation.</p>
- This is a firm-fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Nova Biomedical Corp, a large, privately-owned manufacturer of advanced critical care medical equipment and in-vitro diagnostic devices. The contract, valued at $85,830.50, is for the procurement of BIOPROFILE FLEX2 PARTS AND COMPONENTS - PROCESS ANALYTICAL TECHNOLOGY AND OPTIMIZING INTEGRATION AND AUTOMATED SAMPLING OF ANALYZERS TO BIOREACTOR SYSTEMS. The contract does not have a set-aside...
- This is a $2,797.00 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Nova Biomedical Corporation, a large, private manufacturer of advanced medical equipment and in-vitro diagnostic devices. The contract is for the replacement of up to 300-500 PRIME STAT gas analyzer sensors and cartridges. The contract has an ultimate completion date of July 31, 2025 and does not utilize any set-aside designation. Nova Biomedical is a key supplier of medical...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed-price purchase order to Nova Biomedical Corp, a manufacturer of advanced critical care blood gas analyzers and other in-vitro diagnostic equipment. The contract is for the procurement of one Nova BioProfile Flex 2 nutrient analyzer and accessories for an existing PacBio Sequel instrument at an FDA facility in Silver Spring, Maryland. The total potential value of the contract is $119,699.00. The original...
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $20,940.38 delivery order contract to Biomerieux, Inc. for supplies. The prime contractor Biomerieux, Inc. will perform the work at its Calverton, Maryland facility. The firm fixed price contract runs from May 18, 2022 through July 28, 2026. No additional details were provided regarding the specific supplies requested under the original solicitation. The HHS FDA regulates food and drugs to ensure...
- This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Nova Biomedical Corp, a large, privately-owned manufacturer of advanced medical equipment and in-vitro diagnostic devices. The $64,250.00 contract is for a maintenance agreement on Nova's NOVA BIOPROFILE FLEX equipment. The contract does not utilize a set-aside designation. Nova Biomedical is an experienced federal contractor, holding multiple Blanket Purchase...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $236,975.76 firm-fixed-price purchase order to Nova Biomedical Corp, a manufacturer of in-vitro diagnostic equipment, to procure Nova Bioprofile Flex 2 operational parts and components. This contract has a completion date of January 31, 2024 and was awarded on July 14, 2020 under a full and open competition. The original solicitation was a combined synopsis/solicitation for commercial items under FAR...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Bioexpress, LLC, a for-profit limited liability company, for the delivery of a bead-based homogenizer with accessories. The contract has a ceiling value of $10,076.48 and a completion date of September 26, 2014. It is not associated with any larger contracting vehicle and does not have a set-aside designation. Bioexpress, LLC is the prime contractor, and no subcontractors...
- This federal contract award to Nova Biomedical Corp. by the Department of Health and Human Services Food and Drug Administration is for the delivery of a NOVA FLEX 2 NUTRIENT ANALYSIS CELL COUNTING instrument. The $153,826.00 firm-fixed-price purchase order contract has a completion date of December 31, 2017. The contract does not have a set-aside designation. Nova Biomedical is a manufacturer of advanced critical care blood gas analyzers, testing meters, and other in-vitro diagnostic equipment....